Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

USFDA pauses initiation of new patients on multiple sclerosis evobrutinib drug: Merck

Ruchika Sharma15 April 2023 11:19 AM IST

The company must now place on hold the initiation of new evobrutinib patients and halt studies involving patients who have been taking the drug for...

GSK, Pfizer resolve patent lawsuit over RSV vaccines

Teva, Viatris win US appeal in patent fight over Parkinson's drug

Ruchika Sharma14 April 2023 4:00 PM IST

New Delhi: Belgian biopharmaceutical company UCB on Wednesday lost its U.S. court appeal seeking to revive a patent covering its Parkinson's disease...

Eli Lilly joins trillion-dollar club, fueled by weight loss drug demand boom

Eli Lilly bowel disease drug Mirikizumab rejected by USFDA

Ruchika Sharma14 April 2023 3:00 PM IST

The health regulator cited issues related to the proposed manufacturing of the drug mirikizumab.

R21 Vaccine Not for India Yet, Government Informs Parliament

University of Oxford Malaria vaccine gets regulatory clearance for use in Ghana

Ruchika Sharma14 April 2023 12:07 PM IST

The vaccine has been approved for use in children aged 5 to 36 months, the age group at highest risk of death from malaria.

Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

USFDA accepts application for Merck KEYTRUDA plus Chemotherapy as first line treatment for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Ruchika Sharma14 April 2023 11:00 AM IST

KEYTRUDA is an anti-programmed death receptor-1 therapy that works by increasing the ability of the body's immune system to help detect and fight...

Takeda gets USFDA nod to expand use of HYQVIA to treat primary immunodeficiency in children

Ruchika Sharma14 April 2023 10:00 AM IST

Primary Immunodeficiency is an umbrella term to describe a group of more than 400 disorders that affect the body's immune system, increasing...

Mansukh Mandaviya to hold meeting with e-pharmacies representatives soon

Ruchika Sharma13 April 2023 3:15 PM IST

New Delhi: Union Health Minister Mansukh Mandaviya will soon hold a meeting with the representatives of e-pharmacies that are on government radar over...

Serum Institute Gets NPPA Nod to Discontinue Two Pack Sizes of Tetanus Toxoid Vaccine

Rise in COVID cases: Serum Institute restarts manufacturing of Covishield

Ruchika Sharma13 April 2023 2:15 PM IST

New Delhi: Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday said it has restarted manufacturing of COVID-19 vaccine Covishield amid...

Glenmarks Telma Surpasses Rs 1,000 Crore Revenue, Recognized in Harvard Case Study

Glenmark Pharma weighs selling stake in Glenmark Lifesciences

Ruchika Sharma13 April 2023 1:15 PM IST

Bengaluru: India’s Glenmark Pharmaceuticals Ltd is considering selling a majority of the 82% stake it holds in Glenmark Life Sciences Ltd as it...

Riad Mishlawi to become CEO of Hikma Pharma

Ruchika Sharma13 April 2023 12:15 PM IST

New Delhi: Generic drugmaker Hikma Pharmaceuticals Plc said on Wednesday that Riad Mishlawi, president of the group's injectables business, will...

Boehringer Ingelheim, AnGes sign manufacturing agreement for HGF gene therapy product

Boehringer Ingelheim, Cognizant ink pact on Unified Cloud Platform to speed delivery of life saving therapies

Ruchika Sharma13 April 2023 11:15 AM IST

By bringing together Boehringer Ingelheim's clinical, regulatory, and quality functions onto this unified platform simultaneously, this holistic...

Lupin Nagpur facility completes USFDA inspection

Lupin Diagnostics unveils Regional Reference Laboratory in Bengaluru

Ruchika Sharma12 April 2023 5:45 PM IST

Bengaluru: Global pharma major, Lupin Limited, has announced the launch of its new state-of-the-art Regional Reference Laboratory in Bengaluru,...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok